MTD

Mettler-Toledo International
D

MTD

Arincen80/100B

If you had invested in Mettler-Toledo International ago, it would be worth $4,099 today, against $4,096 in SPY and $6,368 in QQQ.

ArincenArincen ScoreBeta

80/100

Six parts of the company, five checks each, from its own reported figures. A part scores the checks it passes out of 10; the score is their average out of 100.

Profitability7.5

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Cash10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Valuation4

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Growth10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Financial strength10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Shareholders6.7

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Figures to FY2025; the price as of today.

Mettler-Toledo International key facts

Style
Blend stock · 4.3/10Growth 4.3 · Value 3.5
Day range
1,713.14 – 1,737.18
52-week range
1,023.05 – 1,806.58
Market capitalization
34.31B USD
P/E
37.29
PEG ratio
3.26
EPS
46.26
EPS growth forecast (FY2026)
+11.6%
Volume
1,079
Beta
1.17
ESG score
57.4/100Environment 67 · Social 48 · Governance 58
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Patrick K. Kaltenbach
Employees
17K
Website
mt.com
IPO date
14 Nov 1997

Mettler-Toledo International earnings

Next earnings · Q4 FY2026
EPS estimate
14.94 USD
Revenue estimate
1.18B USD
Last quarter · Q3 FY2026
EPS12.57Beat +3.6%Revenue1.09BBeat +2.1%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q4 FY202614.94——+11.83%1.18B——+4.85%
Q3 FY202612.1312.57+3.63%+12.74%1.07B1.09B+2.14%+6.27%
Q2 FY202610.8511.46+5.62%+13.58%1.03B1.03B-0.04%+4.48%
Q1 FY20268.718.91+2.30%+8.79%943.14M947.13M+0.42%+7.17%
Q4 FY202512.8013.36+4.37%+7.66%1.10B1.13B+2.31%+8.10%
Q3 FY202510.6611.15+4.60%+9.21%997.29M1.03B+3.25%+7.87%
Q2 FY20259.6010.09+5.10%+4.56%957.65M983.22M+2.67%+3.85%

Analysts' estimates for FY2026 over the last 7 days:EPS Revenue How the estimates moved

Mettler-Toledo International analyst forecast

12-month price target
1,611.67 USD
-6.58%

Analysts' 1-year price targets range from 1,350.00 to 1,930.00, with an average of 1,611.67.

Past year
1-year forecast
Strong sellStrong buy
Buy
9 ratings
Buy
5
Hold
4
Sell
0

12-month price target

Highest target1,930.00
Average target1,611.67
Lowest target1,350.00
Current price1,725.14

Mettler-Toledo International valuation

Price to earnings ratio (TTM)
37.29
Forward P/E (FY2026)
36.12
Price to sales (TTM)
8.17
Price to book
441.84
EV / EBITDA (TTM)
27.26

Capital structure

Market capitalization
34.31B USD
+
Total debt
2.02B USD
−
Cash and short-term investments
52.24M USD
=
Enterprise value
36.29B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)29.64————
FY2027 (est.)32.6029.64———
FY2026 (est.)36.1232.60———
Now (TTM)37.2933.028.17441.8427.26
FY202533.0629.207.14-1,215.7124.95
FY202430.0929.006.71-204.6622.43
FY202333.6030.047.00-176.7523.84
FY202237.2637.218.291,311.2927.88
FY202151.0443.4110.56229.0037.14

Mettler-Toledo International against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Illumina, Labcorp Holdings, Quest Diagnostics, IQVIA Holdings, Waters, and Agilent Technologies, the US Medical - Diagnostics & Research companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median37.3
    23.852.6
  • Gross marginHighest in 5 years59.4%
    56.7%59.4%
    Against its peers: 2 of 7Peers' median 42.9%
  • Operating marginBelow its median27.8%
    26.8%29.1%
    Against its peers: 2 of 7Peers' median 17.2%
  • Net marginAt its median21.6%
    20.7%22.3%
    Against its peers: 1 of 7Peers' median 13.9%
  • Free cash flow marginBelow its median21.1%
    18.8%22.7%
    Against its peers: 2 of 7Peers' median 14.6%
  • Revenue growthAt its median4.0%
    -3.4%20.5%
    Against its peers: 6 of 7Peers' median 6.9%
  • EPS growthBelow its median3.9%
    -6.5%31.6%
    Against its peers: 4 of 6Peers' median 4.7%
  • Debt to EBITDAHighest in 5 years1.89×
    1.63×1.89×
    Against its peers: 4 of 7Peers' median 2.49×
  • Current ratioAbove its median1.14
    1.021.20
    Against its peers: 5 of 7Peers' median 1.58

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Mettler-Toledo International growth and profitability

Revenue (TTM)
4.20B USD
Net income (TTM)
934.07M USD
Gross margin
59.00%
Operating margin
28.45%
Net margin
22.25%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY20254.03B+3.98%869.19M+0.70%59.37%27.78%21.59%1.24B-0.58%
FY20243.87B+2.22%863.14M+9.43%58.17%29.11%22.29%1.25B+4.12%
FY20233.79B-3.35%788.78M-9.60%57.26%28.50%20.82%1.20B-3.10%
FY20223.92B+5.43%872.50M+13.46%57.19%28.73%22.26%1.24B+12.37%
FY20213.72B+20.51%768.99M+27.58%56.71%26.76%20.68%1.10B+24.93%

Mettler-Toledo International revenue breakdown

By product

FY2025
Laboratory products and services: 55.7%Industrial products and services: 39.2%Retail products and services: 5.1%55.7%Laboratory products and services39.2%Industrial products and services5.1%Retail products and services
SegmentRevenueShare of revenueChange on the year
Laboratory products and services2.24B55.7%+2.5%
Industrial products and services1.58B39.2%+6.0%
Retail products and services205.94M5.1%+4.9%

By region

FY2025
100.0%Asia
RegionRevenueShare of revenueChange on the year
Asia1.19B100.0%+1.7%

How Mettler-Toledo International makes its money

Laboratory products and services2.24B 55.7%
Industrial products and services1.58B 39.2%
Retail products and services205.94M 5.1%
Revenue4.03B 100.0%
Cost of revenue1.64B 40.6%
Gross profit2.39B 59.4%
Research and development199.37M 5.0%
Selling and administration998.31M 24.8%
Other operating expenses74.47M 1.8%
Operating income1.12B 27.8%
Tax179.72M 4.5%
Other expense69.58M 1.7%
Net income869.19M 21.6%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Mettler-Toledo International financial health

Cash and short-term investments
52.24M USD
Total debt
2.02B USD
Net cash
-1.97B USD
Free cash flow (TTM)
870.57M USD
Current ratio
1.10
Debt to equity
26.06
Piotroski score
8 / 9
Altman Z-score
11.81

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY202566.89M2.34B848.65M
FY202459.36M2.13B864.45M
FY202369.81M2.20B860.55M
FY202295.97M2.13B737.83M
FY202198.56M1.80B801.25M

Mettler-Toledo International ownership

Institutions
102.01%
Institutional holders
831 (-10)
Free float
99.45%

Who owns the shares

Institutions 100.0% Others 0.0%
As of 30 Jun 2026

Shares free to trade

Free float 19.78M shares ·99.4% Closely held 109.60K shares ·0.6%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 202602435.00870.00
Q3 2026054.27K8.51K
Q2 2026005.08K0.00
Q1 202601980.001.60K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY202520.61M20.67M-3.04%
FY202421.22M21.32M-2.96%
FY202321.85M21.97M-3.29%
FY202222.49M22.72M-3.15%
FY202123.13M23.46M-3.06%

Source: Financial Modeling PrepVerified against SEC filings

Related Instruments

Title: Mettler/Toledo International

Sector: Healthcare
Industry: Medical - Diagnostics & Research
Mettler-Toledo International Inc. is an American company that supplies precision instruments and services. Its main products and services include retail-weighing solutions, laboratory instruments, industrial instruments, customer and distribution, as well as sales and service. The company also supplies end-of-line inspection systems used in production and packaging for food, pharmaceutical and other industries. It develops a range of precision laboratory instruments for preparing samples, synthesis of materials, analytical benchtop, material characterization, and in-line measurement. Its laboratory instrument portfolio includes laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, and others. The company operates through five segments: US Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. Mettler-Toledo International was founded in 1991 and is headquartered in Columbus, Ohio.

Common questions about Mettler-Toledo International stock